BS Identity and Score for U.S. Food and Drug Administration

AI-powered evaluation using the Model Context Optimization BS Detection Framework, based solely on publicly available website content.

B
BS Level
Government, Municipal & Public Sector
30 Avg BS

Based on 259 businesses audited.

BS Detector

Government, Municipal & Public Sector BS: U.S. Food and Drug Administration (www.fda.gov)

https://www.fda.gov 📍 Industry: Government, Municipal & Public Sector
18 BS / 100

The FDA website provides a masterclass in substantive communication, completely devoid of marketing fluff and jargon-heavy sales language. However, the site is technically crippled in this data sample, with a 100% failure rate on critical sub-pages like ‘Contact’ and ‘About.’ It is a fortress of evidence-based information that suffers from a severe accessibility and structured data deficit.

Info Density Power-words vs. Substance ratio.
0
0% BS
Semantic Coherence Homepage promise vs. Sub-page reality.
8
40% BS
Trust & Proof Verifiable evidence vs. Trust Theatre.
0
0% BS
Commodity Fingerprint Detection of industry clichés/templates.
0
0% BS
Identity & Authority Expert verifiability & Schema depth.
10
67% BS

Fix the technical architecture to ensure that the 510K search, safety recalls, and contact pages do not return ‘Not found’ errors. Implement robust Organization and NewsArticle JSON-LD schema to bridge the authority gap and connect ‘FDA Voices’ to verifiable Person profiles. Replace the generic review_count with direct links to the published audit reports and financial statements as per industry proof expectations. Ensure that technical hierarchy is maintained across the currently empty sub-pages to support the transparency claims made on the homepage.

Info Density Power-words vs. Substance ratio.
0 Impact Weight: 30 / 100
0% BS

The site exhibits zero heading fluff, with H1 and H4 tags utilizing high-specificity nouns and technical terms like ‘Post-Market Assessment Program,’ ‘BHT, ADA,’ and ‘National Priority Voucher Pilot Program.’ Body text maintains a high substance ratio, citing ‘chemical contaminants in infant formula’ and specific gene therapy treatments for ‘genetic hearing loss.’ There is no evidence of concept repetition; every press announcement and featured topic introduces distinct, measurable regulatory actions. Specificity is maximized through the use of exact dates (May 12, 2026) and specific legal/technical frameworks (483s, EUAs, 510Ks).

Blocked resources, unstable DOMs, and redirect heavy paths create blind spots in your semantic graph. Run a full Crawlability & Indexation analysis to map every point where AI loses access to your content.

Semantic Coherence Homepage promise vs. Sub-page reality.
8 Impact Weight: 20 / 100
40% BS

A significant semantic disconnect exists between the high-functioning, content-rich homepage and the five sub-pages analyzed, which all returned ‘Not found’ or insufficient data. While the homepage promises a comprehensive regulatory gateway with links to ‘Warning Letters’ and ‘Import Programs,’ the actual user path terminates in technical dead ends for ‘Contact FDA’ and ‘About FDA’ pages. This technical drift suggests a failure to deliver the ‘Information For’ and ‘Regulatory Information’ structures promised in the homepage H2 and H3 hierarchy. The core identity as a transparent public agency is undermined by the inability of 83% of the sampled pages to provide any substantive content.

Identify the current state and friction diagnosis of your specific business model. Generate your Executive SEO Strategy to quantify the financial or conversion cost of strategic misalignment.

Trust & Proof Verifiable evidence vs. Trust Theatre.
0 Impact Weight: 20 / 100
0% BS

There is no evidence of trust theatre; the site relies on primary regulatory outputs rather than social proof or unverified testimonials. While the page data indicates a review_count of 13, these are not prominently displayed as marketing fluff, and the presence of technical proof links to Guidance Documents provides external validation. The ‘proof_links_count’ of 1 is low for the amount of claims made, but the claims themselves are self-validating regulatory notices.

The ratio of verifiable evidence to assertions is exceptionally high, with every H4 headline serving as a link to a specific outcome or policy change. The site provides high-density proof paths to technical databases (Drug Databases, 510Ks) which function as the ultimate evidence of regulatory activity. There are 8+ instances of specific evidence on the homepage alone, including dates from within 11 days of the temporal anchor.

To see how the system reconstructs a medical entity graph at scale, review the full Cleveland Clinic Structured Data audit. View the Cleveland Clinic Structured Data Audit for a live example of identity level decomposition and cross page entity mapping.

Commodity Fingerprint Detection of industry clichés/templates.
0 Impact Weight: 15 / 100
0% BS

The value proposition is entirely unique and could not be applied to any other entity, given the FDA’s specific oversight of ‘Tobacco Products,’ ‘Radiation-Emitting Products,’ and ‘Vaccines, Blood, and Biologics.’ There is a total absence of generic marketing clichés or value-prop cliches like ‘government that works for you.’ Template fingerprints like ‘Featured Topics’ are populated with high-utility technical shortcuts (483s, EUAs) rather than generic ‘About Us’ boilerplate. The positioning is clearly differentiated through specific regulatory protocols that are non-commoditized.

Identity & Authority Expert verifiability & Schema depth.
10 Impact Weight: 15 / 100
67% BS

A critical technical credibility gap exists as 5 out of 6 pages are ‘Not found,’ failing the requirement for a clean technical implementation. The schema_json is null across the board, which is a major authority gap for a primary government entity that should be utilizing Organization and NewsArticle structured data. While ‘FDA Voices’ is referenced, the lack of Person schema or sameAs links for experts in the provided data prevents full verification of individual digital footprints.

The site avoids vague performance claims in favor of specific regulatory results, such as the ‘Seventh Approval’ under the National Priority Voucher Pilot Program. The marketing tone is strictly objective and news-based, with no ‘proven track record’ fluff without accompanying data. Every claim, such as the ‘Largest-Ever Testing of Infant Formula,’ is supported by specific context regarding the ‘rigorous examination’ and its focus on ‘chemical contaminants.’

Government, Municipal & Public Sector BS: U.S. Food and Drug Administration (www.fda.gov)

BS: 18/ 100

The content perfectly aligns with the Government and Public Sector classification through its focus on regulatory frameworks and public health mandates. Technical identifiers such as 483s, 510Ks, and EUAs confirm its role as a specific regulatory authority rather than a generic service provider.

Every retrieval error rooted in "wrong page surfaced" begins with one failure: unstable URL identity. Read the URL & Canonical Technical Guide to learn how consistent paths and canonical alignment preserve semantic cohesion.

“The BS score of 18 is driven entirely by technical failure and identity gaps rather than content fluff. The Semantic Coherence pillar (8/20) and Identity and Authority pillar (10/15) penalize the 83% failure rate of the sub-pages and the absence of structured data. The content itself scored 0 for BS in Information Density, Trust, and Commodity categories, reflecting its extreme substance.”

Verified Analysis Date: May 19, 2026 © 1EuroSEO Independent Evaluator — Non-Sponsored Result
Get a Strategic Holistic View
FREE TOOLS
BUSINESS STRATEGY

Business Intelligence Engine

×
AI VISIBILITY